DAYMARK WEALTH PARTNERS, LLC

Position in ABBV — AbbVie Inc.

CIK 1956824 CINCINNATI, OH

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$32,828,702

+$14,409,692 QoQ

Shares Held

130,459

+54.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

#461

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DAYMARK WEALTH PARTNERS, LLC holds $218,773,359 across 12 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	266,410	$67,660,147
2	AMGN	Amgen Inc	150,438	$54,476,608
3	ABBV	AbbVie Inc. This page	130,459	$32,828,702
4	LLY	ELI LILLY & Co	25,552	$30,647,837
5	MRK	Merck & Co., Inc.	81,443	$10,465,425
6	NVS	Novartis AG	43,852	$6,872,485
7	BMY	Bristol Myers Squibb Co	85,038	$4,899,889
8	PFE	Pfizer Inc	173,196	$4,170,559

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,828,702	130,459	+54.0%	Shares	Sole	2026-07-31
2026-03-31	$18,419,010	84,689	-0.6%	Shares	Sole	2026-05-11
2025-12-31	$19,475,116	85,234	+0.1%	Shares	Sole	2026-01-12
2025-09-30	$19,712,852	85,138	+4.1%	Shares	Sole	2025-10-22
2025-06-30	$15,186,314	81,814	+2.9%	Shares	Sole	2025-08-04
2025-03-31	$16,664,801	79,538	+1.5%	Shares	Sole	2025-04-23
2024-12-31	$13,930,436	78,393	-1.0%	Shares	Sole	2025-01-17
2024-09-30	$15,640,416	79,200	+3.2%	Shares	Sole	2024-10-08
2024-06-30	$13,163,816	76,748	+79.5%	Shares	Sole	2024-08-14
2024-03-31	$7,787,870	42,767	-0.6%	Shares	Sole	2024-04-10
2023-12-31	$6,667,894	43,027	-8.5%	Shares	Sole	2024-01-09
2023-09-30	$7,011,037	47,035	+15.1%	Shares	Sole	2023-10-10
2023-06-30	$5,508,031	40,882	+15.2%	Shares	Sole	2023-07-19
2023-03-31	$5,655,722	35,488	+11.5%	Shares	Sole	2023-04-20
2022-12-31	$5,144,531	31,833	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.